A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm

NCT05048160 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

272

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Neoplasm

Interventions

DRUG: Intravenous Infusion

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.